BNIP3L and breast carcinoma: Both BNIP3 and BNIP3L/NIX are found to be overexpressed in carcinoma cells of various origins including breast cancer under hypoxic induction [15], and high expression of BNIP3L correlates with shorter disease-free survival time [38].